Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States

References

• Stephens A, Logina I, Liguts V, Aldins P, Eksteina I, Platkajis A, . A parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008; 358:1009–1017.
   PubMed Web of Science ®Google Scholar
• de Bie RM, Gladstone RM, Strafella AP, Ko JH, Lang AE. Manganese-induced parkinsonian associated with methcathinone (ephedrine) abuse. Arch Neurol 2007; 64:886–889.
   PubMed Web of Science ®Google Scholar
• Emerson TS, Cisek JE. Methcathinone: a Russian designer amphetamine infiltrates the rural Midwest. Ann Emerg Med 1993; 22:1897–1903.
   PubMed Web of Science ®Google Scholar
• Lusthof KJ, Oosting R, Maes A, Verschraagen M, Dijjhuizen A, Sprong AGA. A case of extreme agitation and death after the use of mephedrone in the Netherlands. Forensic Sci Intern 2011; 206:e93–e95.
   PubMed Web of Science ®Google Scholar
• Maskell PD, Paoli GD, Seneviratne C, Pounder DJ. Mephedrone (4-methylmethcathinone)-related deaths. J Analyt Toxicol 2011; 35:188–191.
   PubMed Web of Science ®Google Scholar
• Regan L, Mitchelson M, Macdonald C. Mephedrone toxicity in a Scottish emergency department. Emerg Med J 2010 Dec 23. [Epub ahead of print] doi 10.1136/emj.2010.103093.
   Google Scholar
• Durham M. Ivory Wave: the next mephedrone? Emerg Med J 2011 Mar 15. [Epub ahead of print] doi: 10.1136/emj.2011.112920.
   PubMed Web of Science ®Google Scholar
• Wood DM, Davies S, Greene SL, Button J, Holt DW, Ramsey J, Dargan PI. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol 2010; 40:924–927.
   Google Scholar
• Vardakou I, Pistos C, Spiliopoulou C. Drugs for youth via internet and the example of mephedrone. Toxicol Lett (2011) doi: 10.1016/jtoxlet.2010.12.014.
   PubMed Web of Science ®Google Scholar
• Dargan PI, Albert S, Wood DW. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJ Med 2010; 30 July [Epub ahead of print] doi: 10.1039/qjmed/hcq134.
   Google Scholar
• McElrath K, O'Neill C. Experiences with mephedrone pre- and post-legislative control: perceptions of safety and sources of supply. Int J Drug Policy 2011; 22:120–127.
   PubMed Web of Science ®Google Scholar
• Brandt SD, Sumnall HR, Measham F, Cole J. Analyses of second generation “legal highs” in the UK: initial findings. Drug Test Anal 2010; 2:377–382.
   PubMed Web of Science ®Google Scholar
• Karlia L, Reynaud M. GHB and synthetic cathinones: clinical effects and potential consequences. Drug Test Anal (2010) doi: 10.1002/dta.210.
   Web of Science ®Google Scholar
• Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Giffin SL. 2009 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol 2010; 48:979–1178.
   Web of Science ®Google Scholar
• Cozzi NV, Sievert MK, Shulgin AT, Jacob P III, Ruoho AE. Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol 1999; 381:63–69.
   PubMed Web of Science ®Google Scholar
• Nagai F, Nonaka R, Satoh K, Kamimura H. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 2007; 559:132–137.
   PubMed Web of Science ®Google Scholar
• Fuma T, Kodama T, Honda Y, Tanaka T, Kubo Y, Ohashi N, . Influence of methylenedioxypyrovalerone on central nervous system using microdialysis method. ChemBio Integrated Management 2009; 5:62–72.
   Google Scholar
• Durham M. Ivory wave: the next mephedrone? Emerg Med J 2011: doi 10.1136/emj.2011.112920.
   PubMed Web of Science ®Google Scholar
• Archer RP. Fluoromethcathinone, a new substance of abuse. Forens Sci Int 2009; 185:10–20.
   PubMed Web of Science ®Google Scholar
• Wood DM, Davies S, Puchnarewicz M, Button J, Archer R, Ovaska H, . Recreational use of mephedrone (4-methylenemethcathinone, 4-MMC) with associated sympatomimetic toxicity. J Med Toxicol 2010; 6:327–330.
   PubMedGoogle Scholar
• Ojanpera IA, Heikman PK, Rasanen IJ. Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry. Ther Drug Monit 2011; 33:257–263.
   PubMed Web of Science ®Google Scholar
• Kita T, Miyazaki I, Asanuma M, Takeshima M, Wagner GC. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int Rev Neurobiol 2009; 88:43–64.
   PubMed Web of Science ®Google Scholar
• Greene SL, Kerr F, Braitberg G. Review article: amphetamines and related drugs of abuse. Emerg Med Australas 2008; 20:391–402.
   PubMed Web of Science ®Google Scholar
• Wohlfarth A, Weinmann W. Bioanalysis of new designer drugs. Bioanalysis 2010; 2:965–979.
   PubMed Web of Science ®Google Scholar